First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

528 Reviews

Credit Rating - TRIDENT PHARMA CONSULTANTS LIMITED

ANALYSIS
Credit Risk Update: TRIDENT PHARMA CONSULTANTS LIMITED, 1 MANOR COURT, 6 BARNES WALLIS ROAD SEGENSWORTH, FAREHAM, HAMPSHIRE, PO15 5TH. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 31 December 2023. The company was incorporated on 20 September 2012.

The accounts next due date is 30 September 2025. There are no mortgages.

The above was based on public record information as at 5 January 2025 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 08222226
Date Incorporated: 20 September 2012
Date Latest Accounts: 31 December 2023
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 08222226
Annual Return: 20 September 2015
Registered Office: 1 MANOR COURT, 6 BARNES WALLIS ROAD SEGENSWORTH, FAREHAM, HAMPSHIRE, PO15 5TH
SIC Code and Operations: 46900
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

TRIDENT PHARMA CONSULTANTS LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 15 January 2025 Copyright © 2025 First Report Ltd


Recent Searches

Reg No. Reg Name Status
09001924 TRIDENT PHARMA LIMITED Dissolved
15761356 TRIDENT PHARMA LIMITED Active
09785389 TRIDENT PHARMA PROPERTIES LIMITED Active
00404497 TRIDENT PHARMACEUTICALS LIMITED Dissolved
11019962 TRIDENT PHARMACEUTICALS LTD Dissolved

In using this service you agree to the Terms and Conditions

© 2025 First Report Ltd